参桂护心汤治疗冠心病房颤（心阳不振证）的临床疗效观察及对生活质量的影响

发布时间：2018-03-17 20:10

本文选题：参桂护心汤　切入点：冠心病房颤　出处：《黑龙江中医药大学》2017年硕士论文　论文类型：学位论文

【摘要】：目的通过观察参桂护心汤治疗冠心病房颤(心阳不振证)患者的临床疗效及对生活质量的影响,探讨参桂护心汤治疗冠心病房颤(心阳不振证)的有效性。方法本研究通过选择2016年03月～2016年12月在黑龙江中医药大学附属第一医院心内一科门诊患者,诊断适合纳入标准的患者60例。随机将60例患者分为对照组及治疗组,对照组:西医基础治疗加盐酸地尔硫卓缓释胶囊,90mg,1次/日,口服;治疗组:对照组基础上加参桂护心汤,150ml/次,早饭前晚饭后日2次口服,各30例,服药疗程均为1个月。对比两组治疗前后生活质量、心室率、中医证候积分、中医症状疗效的变化。结果1.生活质量变化:治疗组用药前后具有统计学意义(P0.01),对照组用药前后具有统计学意义(P0.05),两组别组间比较具有统计学意义(P0.01),治疗组变化明显优于对照组。2.心室率变化:治疗组用药前后具有统计学意义(P0.01),对照组用药前后具有统计学意义(P＜0.05),两组别组间对比具有统计学意义(P0.01),治疗组变化明显优于对照组。3.中医证候积分改变:治疗组用药前后具有统计学意义(P0.05),对照组用药前后具有统计学意义(P0.05),两组别组间比较具有统计学意义(P0.05),治疗组变化明显优于对照组。4.中医症状疗效改变:治疗组用药前后具有统计学意义(P0.05),对照组用药前后具有统计学意义(P0.05),两组别组间比较具有统计学意义(P0.05),治疗组变化明显优于对照组。结论1、参桂护心汤能够提高冠心病房颤(心阳不振证)患者的生活质量;2、参桂护心汤能够降低冠心病房颤(心阳不振证)患者的心室率;3、参桂护心汤能够改善冠心病房颤(心阳不振证)患者的中医证候积分、中医症候表现。
[Abstract]:Objective to observe the clinical effect of Shengui Huxin decoction in treating coronary heart disease (CHD) patients with atrial fibrillation (XYD) and its effect on quality of life (QOL). To explore the efficacy of Shengui Huxin decoction in the treatment of atrial fibrillation of coronary heart disease (heart yang failure syndrome). Methods from March 2016 to December 2016 in Heilongjiang University of traditional Chinese Medicine, the patients were selected from the first affiliated Hospital of Heilongjiang University of traditional Chinese Medicine. 60 patients were randomly divided into control group and treatment group. The control group was treated with basic western medicine and diltiazem hydrochloride sustained-release capsule 90 mg / d orally. The treatment group: the control group was treated with Shengui Huxin decoction 150 ml / time, and 30 cases were taken orally before and after breakfast, 30 cases were treated for 1 month. The quality of life, ventricular rate and TCM syndrome score were compared before and after treatment. Results 1. Quality of life: the treatment group had statistical significance before and after treatment, the control group had statistical significance before and after treatment, the comparison between the two groups had statistical significance P0.01, the treatment group had the change. The change of ventricular rate in the treatment group was significantly better than that in the control group (P < 0.05). The changes of ventricular rate in the treatment group were significantly better than those in the control group (P < 0.05). The changes in the treatment group were significantly better than those in the control group (P < 0.05). Group 3. Changes of TCM syndromes integral: the treatment group had statistical significance before and after medication, the control group had statistical significance before and after medication, and the comparison between the two groups had statistical significance. The change of the treatment group was obviously better than that of the control group. The change of the curative effect of medical symptoms: the treatment group had statistical significance before and after treatment, the control group had statistical significance before and after treatment, and the comparison between the two groups had statistical significance. The change of the treatment group was obviously better than that of the control group. Gui Huxin decoction can improve the quality of life of patients with coronary heart disease atrial fibrillation (Xinyang failure syndrome), Shen Gui Huxin decoction can reduce the ventricular rate of coronary heart disease patients with atrial fibrillation (heart Yang failure syndrome), and Shengui Huxin decoction can improve coronary heart disease atrial fibrillation. Syndrome integral of traditional Chinese Medicine (TCM) in patients with Heart Yang failure Syndrome, Symptoms of TCM.
【学位授予单位】：黑龙江中医药大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：R259

【参考文献】